Back to search

United Kingdom· GB-APID-535711000001100

Navispare 2.5mg/250microgram tablets

A medicinal product containing amiloride + cyclopenthiazide, registered in United Kingdom by Advanz Pharma.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedNavispare 2.5mg/250microgram tabletsATC—REGISTER NO.GB-APID-5357110000011…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Amiloride + Cyclopenthiazide
Manufacturer
Advanz Pharma
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5021691101888

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c59d6756-d371-4975-80bd-c9638fd966e9
GET /v1/drugs/c59d6756-d371-4975-80bd-c9638fd966e9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "535711000001100",
  "desc": "Navispare 2.5mg/250microgram tablets (Advanz Pharma)",
  "form": "Oral tablet",
  "vpid": "42206011000001105",
  "source": "dmd",
  "vtm_id": "774538002",
  "strength": "2.5 mg",
  "substance": "Amiloride + Cyclopenthiazide",
  "ingredient": "Amiloride hydrochloride",
  "supplier_code": "24129411000001106"
}

See everything about amiloride + cyclopenthiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.